An overactive immune response in the brain may play a role in Dravet syndrome, a rare and severe genetic epilepsy that typically begins in infancy, according to Weill Cornell Medicine researchers.
The protein makes blood vessels leakier to allow metastatic tumors to form in the lungs, according to a study led by investigators at Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center.
Weill Cornell Medicine has received a three-year, $2.5 million grant from the Department of Defense to develop therapies with fewer side effects for triple-negative breast cancer, one of the most aggressive and difficult-to-treat breast cancers.
A new way to measure comorbidity can be used to accurately predict a patient’s risk of hospitalization and future healthcare costs across a population.
An NSAID-related compound called ampyrone appears to safely boost production of the pigment melanin in human skin, according to a preclinical study led by Weill Cornell Medicine and National Eye Institute investigators.
Strict regulations have prevented continental U.S. beekeepers from participating in the lucrative organic honey market, but new findings could provide evidence to open organic markets to U.S. producers.
Weill Cornell Medicine anesthesiologist Dr. Gunisha Kaur has been appointed to the U.S. Commission on International Religious Freedom, an agency that monitors the universal right to freedom of religion or belief.
Researchers have identified a site where a commonly used anesthetic binds to sodium ion channels, revealing a molecular mechanism that may explain how these drugs dampen communication between neurons.